Sales 2024 * | 83.55M 6.66B | Sales 2025 * | 77.08M 6.14B | Capitalization | 18.65M 1.49B |
---|---|---|---|---|---|
Net income 2024 * | -12M -956M | Net income 2025 * | 2M 159M | EV / Sales 2024 * | 0.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.24 x |
P/E ratio 2024 * |
-1.5
x | P/E ratio 2025 * |
6.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.5% |
Latest transcript on Aytu Bioscience Inc
Managers | Title | Age | Since |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15/04/15 |
Jarrett Disbrow
FOU | Founder | 49 | 15/04/15 |
Mark Oki
DFI | Director of Finance/CFO | 55 | 16/01/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vivian Liu
BRD | Director/Board Member | 62 | 30/06/22 |
Jarrett Disbrow
FOU | Founder | 49 | 15/04/15 |
Joshua Disbrow
CEO | Chief Executive Officer | 49 | 15/04/15 |
1st Jan change | Capi. | |
---|---|---|
+29.98% | 682B | |
+31.89% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.42% | 240B | |
+9.37% | 209B | |
-9.24% | 203B | |
+7.09% | 165B |